Carl Zeiss Lecture Award to Rudolf Jaenisch

März 30, 2009

Professor Dr. Rudolf Jaenisch is the winner of the Carl Zeiss Lecture award 2009, the highest scientific commendation granted by the German Association for Cell Biology (DGZ). Jaenisch is a professor at the Massachusetts Institute of Technology (MIT) and a founding member of the Whitehead Institute for Biomedical Research (Cambridge, USA). The award has been conferred annually in recognition of outstanding achievements since 1990. It is linked to a scientific guest lecture which is given by the winner during the annual meeting of the DGZ. Jaenisch is increasingly devoting his attention to therapeutic cloning in animal models and to stem cell research. In 2002 he was the first geneticist to prove that a genetic defect in mice can be cured by therapeutic cloning.
www.zeiss.de/en


International Optoelectronics Expo

März 27, 2009

From Sep. 6-9, 2009 the 11th China International Optoelectronics Expo (CIOE) will take place in the Shenzhen Convention & Exhibition Center in Shenzhen, China. It address to representatives working in the fields of optoelectronics manufacturing, automotive and aerospace, microelectronics manufacturing, semiconductors, mechanical engineering and processing, biotechnology, pharmaceutical technology as well as in research, science and government institutions. The 2009 CIOE will present the three sub-expositions on 70,000 m²:
– Optical communications, sensors, lasers and infrared applications expo
– Precision optics expo
– LED expo

www.opto-china.com


Workshop on Single Molecule Spectroscopy

März 26, 2009

For the 15th time now, PicoQuant is hosting the International Workshop on Single Molecule Spectroscopy and Ultrasensitive Analysis in the Life Sciences. The workshop will take place from Sep. 15-18, 2009 in Berlin-Adlershof, WISTA campus, Germany. Topics that will be covered during the talks and a poster session are: Fluorescence Lifetime Correlation Spectroscopy (FLCS), Pulsed Interleaved Excitation (PIE) and Stimulated Emission Depletion Spectroscopy (STED), two-photon excitation, new and robust fluorophores such as quantum dots, metalfluorophore interactions, analysis of living cells, investigation of protein folding and biological function studies of macromolecules and Foerster Resonance Energy Transfer (FRET).
www.picoquant.com/_workshop.htm


European Biophysics Congress

März 24, 2009

The 7th European Biophysics Congress will take place in Genoa, Italy from July 11-15, 2009. The congress is organized on behalf of the Italian Society of Pure and Applied Biophysics (SIBPA) and the European Biophysics Societies Association (EBSA). It address to representatives from academic and industrial institutions.

Conference topics include:

1. Single molecule biophysics
2. Lipid biophysics
3. Folding/unfolding of proteins
4. Multiscale simulation
5. Chromatin, nucleosomes and molecular machines
6. Glycobiophysics
7. Biomolecular self-assembly
8. Photosensory biophysics
9. Structure-function relationships (channels, pumps, exchangers)
10. Live cell imaging
11. Protein-ligand interactions
12. Membrane microdomains and signalling
13. Biological motility and molecular motors
14. Interaction and recognition of DNA
15. Biomaterials and drug delivery
16. Single molecule fluorescence
17. Imaging and spectroscopy
18. Fluorescent proteins
19. Solar energy conversion and photosynthesis
20. Statistical, soft matter and biological physics
21. Condensed colloidal phase in biology
22. Ion channels in channelopathies and cancer
23. RNA world
24. Stem cells

www.ebsa2009.org

biophysics-congress-genova


3D Single Molecule Imaging

März 20, 2009

A team of researchers led by professor Rafael Piestun of the department of electrical and computer engineering at the University of Colorado and William E. Moerner, professor of chemistry at Stanford University, have demonstrated for the first time a method for three-dimensional optical imaging of objects smaller than 20 nanometers over a wide spatial range. Optical imaging at these scales is of great interest in biomedical sciences and nanotechnology. The new findings, which provide a powerful tool for the super resolution of single molecules, have implications for characterizing defects in materials, the characterization of nanostructures, and the three-dimensional, biophysical and biomedical imaging of tagged molecules inside and outside of cells.
www.stanford.edu
www.colorado.edu

3D single molecule imging

3D single molecule imaging


Emerging Company of the Year Award

März 17, 2009

Seno Medical Instruments, a company engaged in the development of a opto-acoustic cancer platform technology, announced it has received the 2009 North American Medical Imaging Emerging Company of the Year Award from Frost & Sullivan. The Award recognizes Seno Medical Instruments pioneering and pre-clinical opto-acoustic imaging technology, its first product that was commercialized. Seno’s management team will be receiving this award March, 18 in San Francisco.
www.senomedical.com


Partial Wave Spectroscopic Microscopy

März 16, 2009

A team of researchers led by Vadim Backman, professor of biomedical engineering of the Northwestern University, has developed a way to examine cell biopsies and detect never before seen signs of early-stage pancreatic cancer, according to a new paper published online by the OSA journal Optics Letters. The new technique, called „partial wave spectroscopic microscopy“ detects fluctuations in the cells‘ refractive index (an optical property that measure how cells bend light passing through them). These fluctuations are influenced by nanoscopic changes to the cells‘ interior architecture that often occur much earlier than the changes pathologists can detect under their microscopes. The more architectural disorder there is inside the cell, the more the refractive index fluctuates. The researchers showed that by quantifying these fluctuations, partial wave microscopy could identify cancer cells even in cases where they had not been detected by pathologists. Now, the partial wave spectroscopic microscopy has to prove effective in double-blind clinical trails.
www.northwestern.edu